Peter P. Pfreundschuh

2020 - UroGen Pharma Ltd.

In 2020, Peter P. Pfreundschuh earned a total compensation of $1.2M as Chief Financial Officer at UroGen Pharma Ltd., a 14% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$218,800
Option Awards$292,055
Salary$324,329
Stock Awards$176,460
Other$152,313
Total$1,163,956

Pfreundschuh received $324.3K in salary, accounting for 28% of the total pay in 2020.

Pfreundschuh also received $218.8K in non-equity incentive plan, $292.1K in option awards, $176.5K in stock awards and $152.3K in other compensation.

Rankings

In 2020, Peter P. Pfreundschuh's compensation ranked 7,986th out of 13,090 executives tracked by ExecPay. In other words, Pfreundschuh earned more than 39.0% of executives.

ClassificationRankingPercentile
All
7,986
out of 13,090
39th
Division
Manufacturing
3,388
out of 5,618
40th
Major group
Chemicals And Allied Products
1,369
out of 2,251
39th
Industry group
Drugs
1,191
out of 1,951
39th
Industry
Pharmaceutical Preparations
884
out of 1,456
39th

Pay ratio

Peter P. Pfreundschuh's Pay$1,163,956
Median Employee's Pay$222,109
Pay Ratio

5

to 1

In 2020, the annual total compensation of Peter P. Pfreundschuh was $1,163,956.

The annual total compensation of the median employee at UroGen Pharma Ltd. was $222,109.

The ratio of Peter P. Pfreundschuh's pay to the pay of median employee was therefore 5 to one.

Source: SEC filing on April 28, 2021.

Pfreundschuh's colleagues

We found five more compensation records of executives who worked with Peter P. Pfreundschuh at UroGen Pharma Ltd. in 2020.

2020

Elizabeth Barrett

UroGen Pharma Ltd.

Chief Executive Officer

2020

Jason Smith

UroGen Pharma Ltd.

General Counsel

2020

Molly Henderson

UroGen Pharma Ltd.

Chief Financial Officer

2020

Mark Schoenberg

UroGen Pharma Ltd.

Chief Medical Officer

2020

Stephen Mullennix

UroGen Pharma Ltd.

Chief Operating Officer

News

You may also like